Is Xtant Medical Holdings, Inc. (XTNT) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 40.5% / 30% | 7.1% / 30% | 23.8% / 30% | 0.0% / 5% | ✗ NOT HALAL |
| DJIM | 40.5% / 33% | 7.1% / 33% | 23.8% / 33% | 0.0% / 5% | ✗ NOT HALAL |
| MSCI | 37.5% / 33% | 6.6% / 33% | 22.0% / 33% | 0.0% / 5% | ✗ NOT HALAL |
| S&P | 40.5% / 33% | 7.1% / 33% | 23.8% / 33% | 0.0% / 5% | ✗ NOT HALAL |
| FTSE | 37.5% / 33% | 6.6% / 33% | 22.0% / 50% | 0.0% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 62.0% | |
| Operating Margin | 7.6% | |
| Net Margin | 1.3% | |
| Return on Equity (ROE) | 3.6% | |
| Return on Assets (ROA) | 3.9% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$12M |
| Free Cash Flow | -$16M |
| Total Debt | $35M |
| Debt-to-Equity | 64.5 |
| Current Ratio | 2.2 |
| Total Assets | $94M |
Price & Trading
| Last Close | $0.57 |
| 50-Day MA | $0.60 |
| 200-Day MA | $0.66 |
| Avg Volume | 150K |
| Beta | -0.2 |
|
52-Week Range
$0.34
| |
About Xtant Medical Holdings, Inc. (XTNT)
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, which can be compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, the company offers cervical products comprising Spider cervical plating, Streamline OCT, and CervAlign systems; thoracolumbar products consisting of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; and Silex sacroiliac joint fusion systems. Further, it provides interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Xtant Medical Holdings, Inc. (XTNT) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Xtant Medical Holdings, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Xtant Medical Holdings, Inc.'s debt ratio?
Xtant Medical Holdings, Inc.'s debt ratio is 40.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 37.5%.
What are Xtant Medical Holdings, Inc.'s key financial metrics?
Xtant Medical Holdings, Inc. has a market capitalization of $77M, trailing P/E ratio of 55.3, and revenue of $117M. The company maintains a gross margin of 62.0% and a net margin of 1.3%. Return on equity stands at 3.6%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.